Physician

Adam Kevin Chubak, M.D.

According to 2025 Medicare claims, Adam Chubak, M.D. (NPI: 1427477256) practices ophthalmology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF LONG ISLAND (NPI: 1245271600; TIN: 112498332) and primary practice location at 11772-8814. Chubak is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Chubak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 806 traditional Medicare patients, billed 1,818 HCPCS/CPT codes, and received $141,719 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 634 prescription claims across 198 beneficiaries totaling $169,751 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 43 records totaling $1,100. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,840 to $141,719. Similarly, Part D prescription costs have risen steadily, from $14,872 to $169,751. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$71K$142K2020 Medicare payment: $2,840 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $87,515 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $125,931 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $139,974 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $141,719 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201717$2,840
20214021,186$87,515
20225431,654$125,931
20235781,734$139,974
20248061,818$141,719

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$85K$170K2017 Drug cost: $14,872 (USD; Tot_Drug_Cst)2018 Drug cost: $33,642 (USD; Tot_Drug_Cst)2019 Drug cost: $81,082 (USD; Tot_Drug_Cst)2020 Drug cost: $20,054 (USD; Tot_Drug_Cst)2021 Drug cost: $31,604 (USD; Tot_Drug_Cst)2022 Drug cost: $113,877 (USD; Tot_Drug_Cst)2023 Drug cost: $140,553 (USD; Tot_Drug_Cst)2024 Drug cost: $169,751 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201744154$14,872
201884447$33,642
2019121703$81,082
202033153$20,054
202184212$31,604
2022170580$113,877
2023207816$140,553
2024198634$169,751

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system111111$117
92014Established patient complete exam of visual system341341$100
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more156187$82
92012Established patient problem focused exam of visual system137196$67
92250Photography of the retina185186$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast352,114$40,932
RestasisCyclosporine311,650$32,205
MieboPerfluorohexyloctane/Pf21886$21,813
RhopressaNetarsudil Mesylate16710$8,426
CyclosporineCyclosporine221,080$8,374

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.43$1,100Glaukos Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Kevin Chubak, M.D.?

Tedicare shows public-source Medicare data for Adam Kevin Chubak, M.D. (NPI 1427477256), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Kevin Chubak, M.D. have ACO affiliation data?

Adam Kevin Chubak, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Adam Kevin Chubak, M.D.?

Adam Kevin Chubak, M.D. is linked to OPHTHALMIC CONSULTANTS OF LONG ISLAND (billing NPI 1245271600) in the available physician profile data.

Does Adam Kevin Chubak, M.D. have Open Payments data?

Adam Kevin Chubak, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.